FDA Recall Terminated Historical recordClass II
Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only, Manufactured for: Mayne Pharma Greenville, NC 27834
- Reason
- Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.
- Published
- June 29, 2022
- Distribution
- Nationwide
